title: [HELLP syndrome is a life-threatening pregnancy complication. A specific coagulation factor therapy is now possible].
authors: Sektionen för hematologi och koagulation, invärtesmedicinska kliniken sydvästra Skåne, Universitetssjukhuset MAS, Malmö.
authors: E
authors: E
authors: Zetterberg
authors: C
authors: C
authors: Mucchiano
authors: J
authors: J
authors: Westergaard
authors: S
authors: S
authors: Lethagen
authors: E
authors: E
authors: Berntorp
mesh_terms: D000328:Adult; D019774:Blood Coagulation Factor Inhibitors / Q000008:administration & dosage*; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D004630:Emergencies; D005260:Female; D017359:HELLP Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D010951:Plasma Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors